Bambusa Therapeutics, Inc. 10% holder Salvia Investment GmbH purchases $6M in BBTX shares
After the purchase, the filing lists 9,264,301 shares held.
Salvia Investment GmbH, a holder of more than 10% of Bambusa Therapeutics, Inc. (BBTX), bought 375,000 shares on Nov 2 at an average price of $16.00, a total of about $6 million, according to a Form 4 filed on Nov 2.
The purchase was made in the open market, not through an award, an option exercise or a plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 9,264,301 shares held.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Bambusa Therapeutics, Inc. (BBTX) |
|---|---|
| Insider | Salvia Investment GmbH |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 375,000 |
| Average price | $16.00 |
| Value | $6,000,000 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 2, 2026, 4:07 PM ET |
| Shares held after | 9,264,301 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
Read the daily insider trading roundup · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
